Chronic Inflammatory Demyelinating Polyradiculoneuropathy

被引:8
作者
Hughes, Richard [1 ]
机构
[1] Natl Hosp Neurol & Neurosurg, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England
关键词
Chronic inflammatory demyelinating polyradiculoneuropathy; CIDP; IVIG; corticosteroids; immunosuppressants; mechanisms; VASCULITIC NEUROPATHY; CONTROLLED-TRIAL; POLYNEUROPATHY; PROTEIN; METHOTREXATE; CELLS;
D O I
10.1007/s10875-010-9399-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chronic inflammatory demyelinating polyradiculoneuropathy is a chronic progressive or relapsing and remitting disease with a prevalence of up to 8.9 per 100,000. This review discusses possible mechanisms, none of which are proven, and describes the evidence for its treatment. Cochrane Reviews provide evidence that corticosteroids, intravenous immunoglobulin, and plasma exchange are effective short-term treatments. Attempts to confirm the efficacy of other immunosuppressant agents have not been successful, although they are often used in people whose disease is resistant to the first-line treatments. More and better trials are needed.
引用
收藏
页码:S70 / S73
页数:4
相关论文
共 23 条
[21]   Impaired inhibitory Fcγ receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy [J].
Tackenberg, Bjoern ;
Jelcic, Ilijas ;
Baerenwaldt, Anne ;
Oertel, Wolfgang H. ;
Sommer, Norbert ;
Nimmerjahn, Falk ;
Luenemann, Jan D. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (12) :4788-4792
[22]   Ganglioside complexes: new autoantibody targets in Guillain-Barre syndromes [J].
Willison, HJ .
NATURE CLINICAL PRACTICE NEUROLOGY, 2005, 1 (01) :2-3
[23]   P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy [J].
Yan, WX ;
Archelos, JJ ;
Hartung, HP ;
Pollard, JD .
ANNALS OF NEUROLOGY, 2001, 50 (03) :286-292